SpyGlass Pharma, Inc. (SGP) Operating income 2024–2025
SpyGlass Pharma, Inc. (SGP) annual operating income history from SEC filings — each fiscal year as reported.
-$41.4MFY2025 · since FY2024: -$27.1M → -$41.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$41.4M | -53.2% |
| FY2024 | -$27.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice